Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report. | Synapse
February 27, 2026
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report.
Key Points
To explore the efficacy of New FP as a conversion therapy for malignant hepatocellular neoplasms.
Administered New FP as a hepatic arterial infusion regimen.
Monitored the treatment response in liver malignancies.
Evaluated conversion to surgery post-therapy.
New FP achieved significant conversion therapy results.
Demonstrated potential effectiveness in managing rare liver cancers.
Abstract
This case demonstrates the potential of New FP as an effective hepatic arterial infusion regimen capable of achieving conversion therapy in rare liver malignancies such as HCN, NOS.